Literature DB >> 26446969

Nontraumatic Osteonecrosis of the Femoral Head: Where Do We Stand Today? A Ten-Year Update.

Michael A Mont1, Jeffrey J Cherian1, Rafael J Sierra2, Lynne C Jones3, Jay R Lieberman4.   

Abstract

➤ Although multiple theories have been proposed, no one pathophysiologic mechanism has been identified as the etiology for the development of osteonecrosis of the femoral head. However, the basic mechanism involves impaired circulation to a specific area that ultimately becomes necrotic.➤ A variety of nonoperative treatment regimens have been evaluated for the treatment of precollapse disease, with varying success. Prospective, multicenter, randomized trials are needed to evaluate the efficacy of these regimens in altering the natural history of the disease.➤ Joint-preserving procedures are indicated in the treatment of precollapse disease, with several studies showing successful outcomes at mid-term and long-term follow-up.➤ Studies of total joint arthroplasty, once femoral head collapse is present, have described excellent outcomes at greater than ten years of follow-up, which is a major advance and has led to a paradigm shift in treating these patients.➤ The results of hemiresurfacing and total resurfacing arthroplasty have been suboptimal, and these procedures have restricted indications in patients with osteonecrosis of the femoral head.
Copyright © 2015 by The Journal of Bone and Joint Surgery, Incorporated.

Entities:  

Mesh:

Year:  2015        PMID: 26446969     DOI: 10.2106/JBJS.O.00071

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  147 in total

1.  CORR Insights®: CORR® ORS Richard A. Brand Award: Disruption in Peroxisome Proliferator-Activated Receptor- γ (PPARG) Increases Osteonecrosis Risk Through Genetic Variance and Pharmacologic Modulation.

Authors:  Stuart B Goodman
Journal:  Clin Orthop Relat Res       Date:  2019-08       Impact factor: 4.176

2.  Thrombophilia-Associated Factors in Patients with Spontaneous Osteonecrosis of the Knee.

Authors:  Niv Marom; Jonathan Ej Koch; Yiftah Beer; Martin Ellis; Gil Ganot; Meir Nyska; Guy Maoz; Iftach Hetsroni
Journal:  Cartilage       Date:  2018-01-07       Impact factor: 4.634

3.  3D-printed porous titanium changed femoral head repair growth patterns: osteogenesis and vascularisation in porous titanium.

Authors:  Wei Zhu; Yan Zhao; Qi Ma; Yingjie Wang; Zhihong Wu; Xisheng Weng
Journal:  J Mater Sci Mater Med       Date:  2017-03-01       Impact factor: 3.896

Review 4.  Tissue Engineering in Orthopaedics.

Authors:  Alexander M Tatara; Antonios G Mikos
Journal:  J Bone Joint Surg Am       Date:  2016-07-06       Impact factor: 5.284

5.  Core Decompression Augmented With Autologous Bone Marrow Aspiration Concentrate for Early Avascular Necrosis of the Femoral Head.

Authors:  Lucas Arbeloa-Gutierrez; Chase S Dean; Jorge Chahla; Cecilia Pascual-Garrido
Journal:  Arthrosc Tech       Date:  2016-06-13

Review 6.  Stem Cell Therapy for Osteonecrosis of the Femoral Head: Current Trends and Comprehensive Review.

Authors:  Lei Zhao; Alan David Kaye; Aaron J Kaye; Alaa Abd-Elsayed
Journal:  Curr Pain Headache Rep       Date:  2018-05-03

Review 7.  Available Findings Fail to Provide Strong Evidence of the Role of Bone Morphogenic Protein-2 in Femoral Head Osteonecrosis.

Authors:  Ali Parsa; Hamed Vahedi; Karan Goswami; Arash Aalirezaie
Journal:  Arch Bone Jt Surg       Date:  2020-01

8.  Dynamic evolution of osseous structure in osteonecrosis of the femoral head and dynamic collapse risks: a preliminary CT image study.

Authors:  Zeqing Huang; Biao Tan; Hengli Ye; Fanyu Fu; Rongtian Wang; Weiheng Chen
Journal:  J Orthop Surg Res       Date:  2020-11-17       Impact factor: 2.359

Review 9.  Aseptic osteonecrosis of the hip in the adult: current evidence on conservative treatment.

Authors:  Raymond Klumpp; Carlo Trevisan
Journal:  Clin Cases Miner Bone Metab       Date:  2016-04-07

Review 10.  Hip replacement in femoral head osteonecrosis: current concepts.

Authors:  Michelangelo Scaglione; Luca Fabbri; Fabio Celli; Francesco Casella; Giulio Guido
Journal:  Clin Cases Miner Bone Metab       Date:  2016-04-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.